| WelGrace Research Pharmaceuticals |
 | |  | |  |
 |
| |
 |
| |
 |
| |
 |
About Us
The pharmaceutical division of WelGrace
Research Group is dedicated to the
development and commercialization of
existing critical care/emergency products.
Our competencies reside in solving
complex issues through innovative
processes, leading to unique
pharmaceutical products. These
processes include the identification of
drug molecules, conceptual validations,
delivery systems and rapid development
and commercialization strategies.
We establish technical collaborations and partnerships to assist in the areas of
this process that are outside our core competencies.
The pharmaceutical division of WelGrace
Research Group is dedicated to the
development and commercialization of
existing critical care/emergency products.
Our competencies reside in solving
complex issues through innovative
processes, leading to unique
pharmaceutical products. These
processes include the identification of
drug molecules, conceptual validations,
delivery systems and rapid development
and commercialization strategies.
We establish technical collaborations and partnerships to assist in the areas of
this process that are outside our core competencies.
For more information, contact:
Mr. George Owoo
President and CEO
764 Porter Circle, Lindenhurst, IL 60046
Email:owoog@welgrace.com
Telephone 224-372-7918, 908-295-1985 FAX 224-372-7464
Mr. George Owoo
President and CEO
764 Porter Circle, Lindenhurst, IL 60046
Email:owoog@welgrace.com
Telephone 224-372-7918, 908-295-1985 FAX 224-372-7464
|